Andrew Turitz - 01 Sep 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: EVP, CORPORATE DEVELOPMENT
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Sep 2023
Net transactions value: -$9,066
Form type: 4
Filing time: 06 Sep 2023, 16:17:07 UTC
Previous filing: 05 Jun 2023
Next filing: 05 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+1,347	+5.7%		25,114	01 Sep 2023	Direct	F1
transaction	TDOC	Common Stock	Sale	$9,066	-396	-1.6%	$22.89	24,718	05 Sep 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-1,347	-14%	$0.000000	8,087	01 Sep 2023	Common Stock	1,347		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.